0000899243-21-002963.txt : 20210122 0000899243-21-002963.hdr.sgml : 20210122 20210122165954 ACCESSION NUMBER: 0000899243-21-002963 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210119 FILED AS OF DATE: 20210122 DATE AS OF CHANGE: 20210122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dhingra Kapil CENTRAL INDEX KEY: 0001456849 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39200 FILM NUMBER: 21546582 MAIL ADDRESS: STREET 1: 39 BLISS AVENUE CITY: TENAFLY STATE: NJ ZIP: 07670 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Black Diamond Therapeutics, Inc. CENTRAL INDEX KEY: 0001701541 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MAIN STREET, 10TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-417-5868 MAIL ADDRESS: STREET 1: ONE MAIN STREET, 10TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Aset Therapeutics, Inc. DATE OF NAME CHANGE: 20170321 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-19 0 0001701541 Black Diamond Therapeutics, Inc. BDTX 0001456849 Dhingra Kapil C/O BLACK DIAMOND THERAPEUTICS, INC. ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 1 0 0 0 Stock Option (Right to Buy) 27.45 2021-01-19 4 A 0 29842 0.00 A 2031-01-19 Common Stock 29842 29842 D This option shall vest and become exercisable in thirty-six (36) equal monthly installments following the Grant Date. /s/ Brent Hatzis-Schoch, as Attorney-in-Fact 2021-01-22